<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03124394</url>
  </required_header>
  <id_info>
    <org_study_id>Carcinomatosis studyWinterthur</org_study_id>
    <nct_id>NCT03124394</nct_id>
  </id_info>
  <brief_title>Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study</brief_title>
  <official_title>Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of clinical outcome and economical aspects in the treatment of patients with
      peritoneal carcinomatosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peritoneal carcinomatosis is a dooming finding with no hope for cure and a steadily decrease
      in quality of life. Cytoreductive surgery with intraperitoneal chemotherapy (CRS HIPEC)
      offers a small but proven chance for cure. The implementation of a CRS HIPEC and PIPAC
      programme in a Swiss tertiary care hospital is evaluated.

      When a patient is deemed non resectable, pressurized intraperitoneal aerosol chemotherapy
      (PIPAC) administered laparoscopically may confer effective palliation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Postoperative surgical complications</measure>
    <time_frame>90 days</time_frame>
    <description>Reporting and grading of postoperative surgical complications (according to Dindo)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rehospitalisation</measure>
    <time_frame>90 days</time_frame>
    <description>Rehospitalisation: (yes/no), time frame, cause of rehospitalisation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>5 years</time_frame>
    <description>Time to recurrence measured since diagnosis/Intervention (in months)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>5 years</time_frame>
    <description>All cause mortality since diagnosis/Intervention (in months)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of quality of life</measure>
    <time_frame>5 years</time_frame>
    <description>Validated measurements of health-related quality of life according to the EORTC manual in terms of general quality of life: EORTC-QLQ30; disease-specific quality of life: EORTC-CR29 (colorectal cancers), and health-utility (EQ-5D).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>90 days</time_frame>
    <description>At the level of individual patient Cost in terms of hospital charges and expenses in Swiss Francs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revenues</measure>
    <time_frame>90 days</time_frame>
    <description>At the level of individual patient Revenues in Swiss Francs as billed according to the DRG and case-mix index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-utility analysis</measure>
    <time_frame>90 days</time_frame>
    <description>Calculation and comparison of QUALY (quality-adjusted life years derived from EQ-5D) for competing treatment strategies taking advantage of published figures and own data, e.g. cost of a systemic palliative chemotherapy compared to cost of an intraperitoneal chemotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>90 days</time_frame>
    <description>Aggregation of costs, charges, and revenues for the whole series and comparison with alternative treatment option as clinically relevant, chemotherapy alone and palliative surgery alone.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peritoneal Carcinomatosis</condition>
  <arm_group>
    <arm_group_label>CRS and intraoperative chemotherapy</arm_group_label>
    <description>Patients receiving cytoreductive surgery and intraoperative chemotherapy (HIPEC/PIPAC)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with peritoneal carcinomatosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and Women &gt;18 years

          -  Tumour board decision for CRS and intraoperative chemotherapy

        Exclusion Criteria:

          -  Missing Tumour board decision for CRS and intraoperative chemotherapy

          -  Pregnancy

          -  Age &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Adamina, Prof/MD/MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel Adamina, Prof/MD/MSc</last_name>
    <phone>+41522663634</phone>
    <email>Michel.Adamina@ksw.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kantonsspital Winterthur</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <state>ZÃ¼rich</state>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Adamina, Prof/MD/MSc</last_name>
      <phone>+41522663634</phone>
      <email>michel.adamina@ksw.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

